微信关注
Total item
Cart Subtotal
￥ 0.00 产品详情
Regorafenib (BAY 73-4506)是一种多激酶抑制剂，IC50为17、40和69 nM c-KIT，VEGFR2，B-Raf。Regorafenib（BAY 73-4506）是一种针对肿瘤及其脉管系统的口服生物利用型多激酶抑制剂。
Targets
| Target | Value |
|---|---|
| RET | IC50: 1.5nM |
| Raf-1 | IC50: 2.5nM |
| VEGFR2 | IC50: 4.2nM |
| Kit | IC50: 7nM |
| VEGFR1 | IC50: 13nM |
| B-Raf(V600E) | IC50: 19nM |
| PDGFRβ | IC50: 22nM |
| B-Raf | IC50: 28nM |
| VEGFR3 | IC50: 46nM |
| FGFR1 | IC50: 202nM |
| Tie-2 | IC50: 311nM |
| In vitro (25°C) | DMSO | 88 mg/mL (182.26 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
| In vivo | 2% DMSO+30% PEG 300+5% Tween 80+ddH2O | 4 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 20.71 mL | 103.56 mL | 207.13 mL |
| 0.5 mM | 4.14 mL | 20.71 mL | 41.43 mL |
| 1 mM | 2.07 mL | 10.36 mL | 20.71 mL |
| 5 mM | 0.41 mL | 2.07 mL | 4.14 mL |
*The above data is based on the productmolecular weight 482.8. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| 目录号 | A10250 |
|---|---|
| 作用机制 | Inhibitor (抑制剂) |
| M. Wt | 482.8 |
| Formula | C21H15ClF4N4O3 |
| Purity | >99% |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| CAS No. | 755037-03-7 |
| SMILES | CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F |
产品资料
产品标签
Product Questions
Product Questions
No Questions
您还可能对下列产品感兴趣
Cediranib (AZD2171)
Cediranib (AZD2171)是一种高效的VEGFR(KDR)抑制剂，此外对c-Kit和PDGFRβ也具有相似的抑制活性，对VEGFR的选择性比P…
Buflomedil HCl
Buflomedil HCl是一种用于治疗外周血管疾病的血管活性剂。
LGX 818 (Encorafenib)
LGX 818 (Encorafenib)是一种Raf激酶抑制剂，具有潜在的抗肿瘤活性。
Pazopanib HCl (GW786034)
Pazopanib HCl (GW786034)是VEGFR-1，VEGFR-2，VEGFR-3，PDGFR-a/β和c-kit的有效且选择性的多靶点酪氨酸激酶抑制剂，可…
MLN2480 (BIIB-024)
MLN2480 (BIIB-024)是一种口服的Raf激酶抑制剂。
Keywords:购买 Regorafenib (BAY 73-4506) | Regorafenib (BAY 73-4506) 供应商 | 订购 Regorafenib (BAY 73-4506) | Regorafenib (BAY 73-4506) 价格 | Regorafenib (BAY 73-4506) 生产商 | 订单 Regorafenib (BAY 73-4506) | Regorafenib (BAY 73-4506) 代理商 | 购买 755037-03-7| 755037-03-7 供应商 | 订购 755037-03-7 | 755037-03-7 价格 | 755037-03-7 生产商 | 订单 755037-03-7 | 755037-03-7 代理商|buy Regorafenib (BAY 73-4506) | Regorafenib (BAY 73-4506) Supplier | purchase Regorafenib (BAY 73-4506) | Regorafenib (BAY 73-4506) cost | Regorafenib (BAY 73-4506) manufacturer | order Regorafenib (BAY 73-4506) | Regorafenib (BAY 73-4506) distributor | buy 755037-03-7| 755037-03-7 Supplier | purchase 755037-03-7 | 755037-03-7 cost | 755037-03-7 manufacturer | order 755037-03-7 | 755037-03-7 distributor